Augmented β2-AR signalling is also considered cardio-protective [24], and the idea that β2-AR agonism may be beneficial in clinical HF is long-standing [40], but remains controversial and poorly studied in humans. The gene discussed is ADRB2; the disease is hydrops fetalis.